U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H17N5
Molecular Weight 291.3504
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BL-1249

SMILES

C1CCC2=C(NC3=CC=CC=C3C4=NNN=N4)C=CC=C2C1

InChI

InChIKey=YYNRZIFBTOUICE-UHFFFAOYSA-N
InChI=1S/C17H17N5/c1-2-8-13-12(6-1)7-5-11-15(13)18-16-10-4-3-9-14(16)17-19-21-22-20-17/h3-5,7,9-11,18H,1-2,6,8H2,(H,19,20,21,22)

HIDE SMILES / InChI

Molecular Formula C17H17N5
Molecular Weight 291.3504
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

BL-1249 is a putative activator of potassium TREK-1 channel. BL-1249 produced a concentration-dependent membrane hyperpolarization of cultured human bladder myocytes, assessed as either a reduction in fluorescence of the voltage-sensitive dye bis-(1,2-dibutylbarbituric acid)trimethine oxonol (EC50 = 1.26 +/- 0.6 uM) or by direct electrophysiological measurement (EC50 = 1.49 +/- 0.08 uM). BL-1249 also produced a membrane hyperpolarization of acutely dissociated rat bladder myocytes. Voltage-clamp studies in human bladder cells revealed that BL-1249 activated an instantaneous, noninactivating current that reversed near E(K). BL-1249 behaves as a potassium channel activator that exhibits bladder versus vascular selectivity both in vitro and in vivo.

Originator

Curator's Comment: # Bristol-Myers Squibb

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties.
2005 Apr
Patents

Sample Use Guides

Rat: In an anesthetized rat model, BL-1249 (1 mg/kg i.v.) decreased the number of isovolumic contractions, without significantly affecting blood pressure.
Route of Administration: Intravenous
In in vitro organ bath experiments, BL-1249 produced a concentration-dependent relaxation of 30 mM KCl-induced contractions in rat bladder strips (EC50 = 1.12 +/- 0.37 uM), yet had no effect on aortic strips up to the highest concentration tested (10 uM).
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:59:42 GMT 2023
Edited
by admin
on Sat Dec 16 07:59:42 GMT 2023
Record UNII
5E7RR1J6TR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BL-1249
Common Name English
1-NAPHTHALENAMINE, 5,6,7,8-TETRAHYDRO-N-(2-(1H-TETRAZOL-5-YL)PHENYL)-
Systematic Name English
1H-TETRAZOLE, 5-(O-((5,6,7,8-TETRAHYDRO-1-NAPHTHYL)AMINO)PHENYL)-
Systematic Name English
1-NAPHTHALENAMINE, 5,6,7,8-TETRAHYDRO-N-(2-(2H-TETRAZOL-5-YL)PHENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
5E7RR1J6TR
Created by admin on Sat Dec 16 07:59:42 GMT 2023 , Edited by admin on Sat Dec 16 07:59:42 GMT 2023
PRIMARY
CAS
18200-13-0
Created by admin on Sat Dec 16 07:59:42 GMT 2023 , Edited by admin on Sat Dec 16 07:59:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID70171231
Created by admin on Sat Dec 16 07:59:42 GMT 2023 , Edited by admin on Sat Dec 16 07:59:42 GMT 2023
PRIMARY
PUBCHEM
16078951
Created by admin on Sat Dec 16 07:59:42 GMT 2023 , Edited by admin on Sat Dec 16 07:59:42 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY